Gene · 2053
Papers2,484
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,484
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Feasibility of a Multi-Laboratory Model of Middle Cerebral Artery Thromboembolic Stroke with Thrombolysis: TE-MCAo. | Transl Stroke Res | 2026 | 41611917 | PubTator, text mining | PubMed |
| Artificial Intelligence Driven Virtual Screening and Molecular Docking Approaches Identified LIFR, BTG2, EPHX2, and PAK3 as Targets and BI-2536, AP-24534, and AZ-628 as Repurposed Drugs for PDAC. | IEEE Trans Comput Biol Bioinform | 2026 | 41605175 | PubTator, text mining | PubMed |
| Decrypting potential mechanisms linking ochratoxin A to hepatocellular carcinoma: an integrated approach combining toxicology, machine learning, molecular docking, and molecular dynamics simulation. | BMC Pharmacol Toxicol | 2026 | 41593793 | PubTator, text mining | PubMed |
| Which halogen to choose? Comparing the effects of chlorine and fluorine as bioisosteric substituents in drug design. | Chem Sci | 2026 | 41561465 | PubTator, text mining | PubMed |
| Novel fatty acid amide hydrolase (FAAH) inhibitors: a patent review from 2015 to 2025. | Expert Opin Ther Pat | 2026 | 41559860 | PubTator, text mining | PubMed |
| Epoxy-oxylipins direct monocyte fate in inflammatory resolution in humans. | Nat Commun | 2026 | 41545341 | PubTator, text mining | PubMed |
| The liver as a metabolic and immune hub in Alzheimer's disease: From mechanisms to therapeutic opportunities. | J Prev Alzheimers Dis | 2026 | 41529520 | PubTator, text mining | PubMed |
| SMTP-44D Improves High Glucose-Induced Vascular Endothelial Dysfunction. | Biol Pharm Bull | 2026 | 41526227 | PubTator, text mining | PubMed |
| Potential Nutraceutical Properties of Vicia faba L: LC-ESI-HR-MS/MS-Based Profiling of Ancient Faba Bean Varieties and Their Biological Activity. | Molecules | 2026 | 41515480 | PubTator, text mining | PubMed |
| Target Abundance in Pharmacological Target-Mediated Drug Disposition (TMDD) for Small Molecules - A Proteomics Approach. | AAPS J | 2026 | 41495534 | PubTator, text mining | PubMed |
| Organ cross-talk: molecular mechanisms, biological functions, and therapeutic interventions for diseases. | Signal Transduct Target Ther | 2026 | 41491917 | PubTator, text mining | PubMed |
| Distinct Single-Cell Expression Pattern of the Soluble Epoxide Hydrolase and Cytochrome p450 Epoxygenases in Human and Mouse Small Intestinal Epithelia. | J Histochem Cytochem | 2026 | 41449646 | PubTator, text mining | PubMed |
| Polynitrogen-containing compounds as multi-target sEH/FAAH inhibitors: Structure-activity relationship and pharmacological studies. | Bioorg Med Chem | 2026 | 41289658 | PubTator, text mining | PubMed |
| CYP4X1/sEH-Dependent Endocannabinoid Metabolism Drives Fibroblast-Mediated Immunosuppression to Limit Immunotherapy in Colon Cancer. | Adv Sci (Weinh) | 2026 | 41276938 | PubTator, text mining | PubMed |
| Integrated bioinformatics to identify and validate the role of oxidative stress-related gene EPHX2 in laryngeal cancer. | Eur Arch Otorhinolaryngol | 2026 | 41269267 | PubTator, text mining | PubMed |
| Strategies for developing dual-targeted soluble epoxide hydrolase inhibitors. | Eur J Med Chem | 2026 | 41240618 | PubTator, text mining | PubMed |
| An adamantylureido-benzylamide aniline as FLAP/sEH dual inhibitor: Rational design, in vitro and in vivo lipidomic profiling. | Eur J Med Chem | 2026 | 41197472 | PubTator, text mining | PubMed |
| Targeted Deletion of EPHX2 in Intestinal Epithelial Cells Alleviates DSS-Induced Colitis by Enhancing Goblet Cell Differentiation. | Cell Biol Int | 2026 | 41165251 | PubTator, text mining | PubMed |
| Unraveling the mechanisms of matrine in esophageal cancer treatment: insights from network pharmacology, bioinformatics, and molecular biology experiments. | J Asian Nat Prod Res | 2026 | 41160660 | PubTator, text mining | PubMed |
| Exploring the role of cytochrome P450 family 1 subfamily B member 1 and quercetin in modulating neuropathic pain after spinal cord injury. | Mol Med Rep | 2026 | 41104896 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2053/papers?page=4